[Selection of proton pump inhibitors in polymorbid patients].
Iu P
IuP
Uspenskiĭ
I G
IG
Pakhomova
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002755:Choice Behavior; D003920:Diabetes Mellitus / Q000188:drug therapy; D004347:Drug Interactions; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D017202:Myocardial Ischemia / Q000150:complications / Q000188:drug therapy; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D055034:Osteochondrosis / Q000150:complications / Q000188:drug therapy; D010818:Practice Patterns, Physicians'; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D054328:Proton Pump Inhibitors